Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2006235022 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Cox, Christopher D.; Coleman, Paul J.

Agent Spruson & Ferguson

Pub. Number AU-B-2006235022

PCT Pub. Number WO2006/110390

Priority 60/669,085 07.04.05 US

Filing date 3 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 21 July 2011

International Classifications

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/110390 Priority application(s): WO2006/110390

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

21 July 2011 Application Accepted

  Published as AU-B-2006235022

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235024-Method and system for risk management in a transaction

2006235018-Composition comprising particulate zinc material with a high relative zinc lability